We examined conversion of LC3B-I to LC3B-II in HNK-treated breast cancer cells, and found a time-dependent increase in LC3B-II (LC3B) in MCF7, MDA-MB-231, MDA-MB-468, SUM159, and SUM149 cells (Fig. 1d). Here, MAP1LC3B is linked to breast cancer.